[Investigation of the physico-chemical properties of deramciclane (EGIS-3886), a new anxiolytic compound. Ionization and lipophilicity].
Ionization and lipophilicity of deramciclane hydrogenfumarate (EGIS-3886), a novel anxiolytic compound being under clinical trial were investigated. The aqueous pKa value and the octanol/water partition coefficient (logP) have been determined using validated analytical approaches. The favourable pharmacokinetic properties of deramciclane are interpreted on the bases of its ionization capability and extreme high lipophilicity.